EYPT
$21.84
Revenue | $14.03Mn |
Net Profits | $-14.1Mn |
Net Profit Margins | -100.51% |
Eyepoint Pharmaceuticals Inc’s revenue jumped 33.18% since last year same period to $14.03Mn in the Q4 2023. On a quarterly growth basis, Eyepoint Pharmaceuticals Inc has generated -7.72% fall in its revenue since last 3-months.
Eyepoint Pharmaceuticals Inc’s net profit jumped 78.02% since last year same period to $-14.1Mn in the Q4 2023. On a quarterly growth basis, Eyepoint Pharmaceuticals Inc has generated -11.79% fall in its net profits since last 3-months.
Eyepoint Pharmaceuticals Inc’s net profit margin jumped 83.5% since last year same period to -100.51% in the Q4 2023. On a quarterly growth basis, Eyepoint Pharmaceuticals Inc has generated -21.15% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.41 |
EPS Estimate Current Year | -0.41 |
Eyepoint Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.41 - a 16.33% jump from last quarter’s estimates.
Eyepoint Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.41.
Earning Per Share (EPS) | -0.33 |
Eyepoint Pharmaceuticals Inc’s earning per share (EPS) jumped 71.55% since last year same period to -0.33 in the Q4 2023. This indicates that the Eyepoint Pharmaceuticals Inc has generated 71.55% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-12-31 | -0.49 | -0.33 | 32.65% |
2023-08-04 | 0.6 | -0.61 | -201.67% |
2023-11-03 | -0.51 | -0.33 | 35.29% |
2023-05-04 | -0.68 | -0.56 | 17.65% |